Study Title: NRG-GU011: A Phase II Double-Blinded, Placebo-Controlled Trial of Prostate Oligometastatic Radiotherapy With Or Without Androgen Deprivation Therapy In Oligometastatic Prostate Cancer (NRG PROMETHEAN)
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Lally, Brian, at lallyb@musc.edu.Study Coordinator, Everett, Talia, at everettt@musc.edu.Trial opened at the following institutions: Medical University of South Carolina, Ralph H. Johnson VAMC